Name: Crispr Therapeutics Ag's (CRSP) Earnings Release Date
Start: 2025-05-07T20:0000Z
Location: Crispr Therapeutics Ag

CRSP

$33.16

Crispr Therapeutics Ag

($4.46)

(11.86%)

CRSP

Earnings Whisper ®

N/A

1st Quarter March 2025

Consensus: ($1.27)

Revenue: $5.24 Mil

Wednesday

May 7

4:00 PM ET

Score

Grade

Tweet Share Watch

Tweet Share Watch

Latest EPS

Tuesday, May 6, 2025 at 4:01:00 PM ET

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

What do you expect when CRSP reports earnings?

Beat

Meet

Miss

Where is CRSP's stock price going from here?

Flat

Down

Analysts

Score

Grade

Sentiment

Analysts

Pivots

Resistance

$39.68

$38.33

$35.74

$34.39

Support

$31.80

$30.45

$27.86

Trends

Short-term Price

Intermediate-term Price

Long-term Price

Investors' Sentiment

Analysts' Sentiment

Earnings Estimates

Growth

Description

CRISPR Therapeutics AG is a leading gene editing company focused on developing CRISPR/Cas9-based therapeutics. The company is rapidly leveraging its CRISPR/Cas9 gene-editing platform to make therapies for the treatment of hemoglobinopathies, cancer, diabetes and other diseases.